China set to dominate prescription drug markets

Mar 25 2010

New reports indicate that prescription drug sales in emerging markets will grow quickly, especially in the hugely influential market of China.  In fact, China's pharmaceutical market continues to expand its dominance and clout at an astonishing rate.

China is on track to becoming one of the world's largest prescription drug markets.  Rapid growth will only continue to happen as this country examines and works on its healthcare system.  However, China's constantly changing legal, regulatory, and market environments pose a big challenge to foreign companies trying to succeed in such a fertile marketplace.

However, there are experts who can anticipate what will happen next as they are constantly in touch with top Chinese government officials, industry association leaders, and senior level executives at pharmaceutical companies.  Fortunately, those experts will be at "Pharma China Seminar - Building Success in China's Pharma Sector" on April 29, 2010 at the Crowne Plaza Fairfield in New Jersey and November 4, 2010, venue TBA.  

These experts will be available to educate anyone who needs to know about the Chinese pharmaceutical industry in just ONE day!  This unique Pharma China Seminar is jam packed with the most recent, hard-to-find data, exclusive information, and real-world, hands-on experience that can't be found anywhere else.

"Pharma China Seminar - Building Success in China's Pharma Sector" will focus on the latest trends and issues in drug regulation and healthcare policies, pharma marketing and distribution channels, the regulatory process for new drug development, as well as intellectual property and legal issues.

At the Pharma China Seminar, leading experts of the Chinese pharmaceutical/healthcare sector with different specializations will share their expertise and knowledge through exclusive data, detailed analysis, case studies and interactive panel discussions.

Pharma China Seminar is the most important and relevant discussion about the rising importance of China in the pharmaceutical industry.  Based on feedback from 2009, 2010 has resulted in an even improved program with added depth and breadth to such a dynamic topic. Anyone who wants to get ahead in the pharmaceutical industry, especially in the areas of emerging markets, cannot afford to miss this event!